Trademark: 79355607
Word
INVIOS
Status Date
Monday, April 22, 2024
Filing Date
Tuesday, June 21, 2022
Published for Opposition
Tuesday, January 9, 2024
5 Pharmaceutical and veterinary pharmaceutical preparations and substances for treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; diagnostic preparations for medical purposes in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; biopharmaceutical, biological and chemical preparations and substances for medical use in the nature of treatment of cancer, regulating the immune system, treatment of immune system diseases and disorders, and for cell therapy; pharmaceutical and veterinary pharmaceutical preparations and substances for the treatment of cancer, regulation of the immune system, treatment of diseases of the immune system and cell therapy
1 Chemical, biochemical and biotechnological preparations used in industry and science
10 Surgical and veterinary apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical diagnostic apparatus for testing blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; medical apparatus and instruments for the treatment and prevention of cancer, for the regulation of the immune system, for the treatment of diseases of the immune system, for cell therapy; medical apparatus and instruments for preparing and processing blood and other cell preparations for medical purposes in the nature of cancer treatment, regulation of the immune system and treatment of diseases of the immune system and cell therapy; medical apparatus and instruments for cell therapy; parts for the aforesaid goods, included in this class and only for purposes before mentioned
42 Scientific and technological services, namely, research and design in the fields of oncology, immunology and cell therapy; scientific and technological analysis services in the field of research, development and diagnostics; industrial analysis of blood cells, cancer cells and immune cells as therapeutic agents and modifications thereof; industrial research services in the field of oncology, immunology and cell therapy; scientific and medical research in the field of cancer or diseases of the immune system; research and development in the field of oncology, immunology and cell therapy
Mar 31, 2023
Assigned To Examiner
Nov 17, 2022
Sn Assigned For Sect 66a Appl From Ib
Nov 18, 2022
New Application Office Supplied Data Entered
Nov 22, 2022
Application Filing Receipt Mailed
Apr 6, 2023
Non-Final Action Written
Apr 7, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Jun 5, 2023
Refusal Processed By Mpu
Jun 5, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jun 26, 2023
Refusal Processed By Ib
Nov 4, 2023
New Representative At Ib Received
Nov 28, 2023
Teas Response To Office Action Received
Nov 28, 2023
Correspondence Received In Law Office
Nov 29, 2023
Teas/Email Correspondence Entered
Nov 29, 2023
Approved For Pub - Principal Register
Dec 20, 2023
Notification Of Possible Opposition Sent To Ib
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Jan 8, 2024
Notification Processed By Ib
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 13, 2024
Teas Post Publication Amendment Received
Apr 17, 2024
Notification Of Possible Opposition Sent To Ib
Apr 17, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 20, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 9, 2024
Published For Opposition
Feb 5, 2024
Extension Of Time To Oppose Received
Apr 22, 2024
Assigned To Petition Staff
Apr 22, 2024
Changes/Corrections After Pub Approval Entered
May 7, 2024
Notification Of Possible Opposition - Processed By Ib
May 19, 2024
Extension Of Time To Oppose Process - Terminated
Trademark Alertz updated from USPTO on 2030-01-24
